Serological diagnosis of Chagas disease: Evaluation of cross reaction in patients with visceral leishmaniasis
Keywords:Trypanosoma cruzi; Leishmania; Serologic tests; Cross reactions.
In Brazil, there are several simultaneously endemic regions for leishmaniasis and Chagas disease and, as the causative agents both belong to the same family, Trypanosomatidae, they share several antigens, which at the time of serological diagnosis can promote cross reactions. Several authors have evaluated Chagas/leishmaniasis cross reaction in dogs, however few studies have made this question in humans. The objective of this study was to identify the possibility of cross reaction for the diagnosis of Chagas disease in patients with cured visceral leishmaniasis. Therefore, thirty serum samples from patients with cured visceral leishmaniasis at the Infectious Diseases Clinic of the Hospital Regional de Presidente Prudente, São Paulo were analyzed. The samples were evaluated using three serological kits for the diagnosis of Chagas disease: immunoenzymatic assay (ELISA), indirect immunofluorescence (IFI) and indirect hemagglutination (HAI). Of the 30 samples analyzed, only one patient's serum showed to be reagent in the IFI, however, the duplicate evaluated was not positive, as well as the ELISA and HAI results. In the present study, due to the reactivity for the IFI to present in only one marked T. cruzi, with its duplicate and other serological tests (ELISA and HAI) negative, we can conclude that the patient with visceral leishmaniasis presented a cross reaction for the diagnosis of Chagas disease.
Aguirre, S., Silber, A. M., Brito, M. E., Ribone, M. E., Lagier, C. M., & Marcipar, I. S. (2006). Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection. Journal of clinical microbiology, 44(10), 3768–3774.
Caballero, Z. C., Sousa, O. E., Marques, W. P., Saez-Alquezar, A., & Umezawa, E. S. (2007). Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clinical and vaccine immunology: CVI, 14(8), 1045–1049.
Dias, J. C. P. et al. (2016). Consenso Brasileiro em Doença de Chagas. Epidemiol Serv Saúde, 25(esp), 7-86.
Ferreira-Silva, M. M., Carvalho, S. F. G., Lula, J. F., Teles, L. de F., Basques, F. V., Teixeira, L. A. S., Tibúrcio, Monique Gomes Sales & Moraes-Souza, H. (2017). Evaluation of cross reactivity between Trypanosoma cruzi and Leishmania infantum in serologically ineligible blood donors due to chagas disease. Rev Patol Trop., 46(1), 113-119.
França, A. O., Pompilio, M. A., Pontes, E., de Oliveira, M. P., Pereira, L., Lima, R. B., Goto, H., Sanchez, M., Fujimori, M., Lima-Júnior, M., Matos, M., & Dorval, M. (2018). Leishmania infection in blood donors: A new challenge in leishmaniasis transmission? PloS one, 13(6), e0198199.
Gontijo, C. M. F. & MELO, M. N. (2004). Visceral Leishmaniasis in Brazil: current status, challenges and prospects. Rev Bras Epidemiol., 7(3), 338-49.
Luciano, R. M., Lucheis, S. B., Troncarelli, M. Z., Luciano, D. M., & Langoni, H. (2009). Cross reaction evaluation of Leishmania spp and Trypanosoma cruzi antigens in dogs’ serologic response by indirect immunofluorescence test (IIF). Brazilian Journal of Veterinary Research and Animal Science, 46(3), 181-187.
Luz, K. G., da Silva, V. O., Gomes, E. M., Machado, F. C., Araujo, M. A., Fonseca, H. E., Freire, T. C., d'Almeida, J. B., Palatnik, M., & Palatnik-de Sousa, C. B. (1997). Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and multiply transfused hemodialysis patients. The American journal of tropical medicine and hygiene, 57(2), 168–171.
Martins-Melo, F. R., Ramos, A. N., Jr, Alencar, C. H., & Heukelbach, J. (2014). Prevalence of Chagas disease in Brazil: a systematic review and meta-analysis. Acta tropica, 130, 167–174.
Mascolli, R., Soto, F. R. M., Pinheiro, S. R., Ito, F. H., Gil, A., Azevedo, S. S., Lima, V. M. F., Langoni, H., Fernandes, A. R. F. & Vasconcellos, S. A. (2016). Prevalence and risk factors for leishmaniasis and Chagas disease in the canine population of the tourist city of Ibiúna, São Paulo, Brazil. Semina: Ciencias Agrarias, 37(4), 1971-80.
Matos, H. J., Pinto, A. Y. N., Miranda, A. M. M., Silva, F. L. C. & Ramos, F. L. P. (2015). Reação cruzada nos testes sorológicos entre doença de Chagas e leishmaniose visceral em regiões endêmicas para ambas as doenças. Revista Pan-Amazônica de Saúde, 6(1), 65-68.
Ministério da Saúde (MS). Manual de vigilância e controle da Leishmaniose Visceral, 2014, 1ºed – Brasília.
Oliveira, A. M., Vieira, C. P., Dibo, M. R., Guirado, M. M., Rodas, L., & Chiaravalloti-Neto, F. (2016). Dispersal of Lutzomyia longipalpis and expansion of canine and human visceral leishmaniasis in São Paulo State, Brazil. Acta tropica, 164, 233–242.
Pan American Health Organization (PAHO). (2020). 10 vector-borne diseases that put the population of the Americas at risk. https://www.paho.org/hq/index.php?option=com_content&view=article&id=9438:2014-10-vector-borne-diseases-that-put-population-americas-at-risk&Itemid=135&lang=pt
Perez, T. D., Figueiredo, F. B., Velho Junior, A. A. M., Silva, V. L., Madeira, M. F., Brazil, R. P. & Coura, J. R. (2016). prevalence of american trypanosomiasis and leishmaniases in domestic dogs in a rural area of the municipality of São João do Piauí, Piauí State, Brazil. Revista do Instituto de Medicina Tropical de São Paulo, 58(79), Epub November 03.
Prestes-Carneiro, L. E., Daniel, L., Almeida, L. C., D'Andrea, L. Z., Vieira, A. G., Anjolete, I. R., André, L., & Flores, E. F. (2019). Spatiotemporal analysis and environmental risk factors of visceral leishmaniasis in an urban setting in São Paulo State, Brazil. Parasites & vectors, 12(1), 251.
Silva, L. P., Montenegro, S., Werkauser, R., Sales, K. G. S., Soares, F. C. S., Costa, V. M. A., Bezerra, A. C., Pinto, M. B. A., Ferreira, S. M., Neitzke-Abreu, H. C., Dantas-Torres, F. & Lima Junior, M. S. C. (2020). Asymptomatic Leishmania infection in blood donors from a major blood bank in Northeastern Brazil: a cross-sectional study. Revista do Instituto de Medicina Tropical de São Paulo, 62, e92.
Slavov, S. N., Otaguiri, K. K., Pinto, M. T., Valente, V. B., Ubiali, E. M., Covas, D. T., & Kashima, S. (2017). Prevalence of Trypanosoma Cruzi antibodies in blood donors from the Sao Paulo State, Brazil, between 2012 and 2014. Journal of infection in developing countries, 11(3), 277–281.
Toledo, C. R. S., Almeida, A. S., Chaves, S. A. M., Sabroza, P. C., Toledo, L. M. & Caldas, J. P. (2017). Vulnerability to the transmission of human visceral leishmaniasis in a Brazilian urban area. Revista de Saúde Pública, 51, 49.
Umezawa, E. S., Bastos, S. F., Camargo, M. E., Yamauchi, L. M., Santos, M. R., Gonzalez, A., Zingales, B., Levin, M. J., Sousa, O., Rangel-Aldao, R., & da Silveira, J. F. (1999). Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America. Journal of clinical microbiology, 37(5), 1554–1560.
Umezawa, E. S., Luquetti, A. O., Levitus, G., Ponce, C., Ponce, E., Henriquez, D., Revollo, S., Espinoza, B., Sousa, O., Khan, B., & da Silveira, J. F. (2004). Serodiagnosis of chronic and acute Chagas' disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin American countries. Journal of clinical microbiology, 42(1), 449–452.
Vega Benedetti, A. F., Cimino, R. O., Cajal, P. S., Juarez, M., Villalpando, C. A., Gil, J. F., Marcipar, I. S., Krolewiecki, A. J., & Nasser, J. R. (2013). Performance of different Trypanosoma cruzi antigens in the diagnosis of Chagas disease in patients with American cutaneous leishmaniasis from a co-endemic region in Argentina. Tropical medicine & international health : TM & IH, 18(9), 1103–1109.
World Health Organization (WHO). (2013). Department of Control of Neglected Tropical Diseases. Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected tropical diseases. file:///C:/Users/TEMP.LAPTOP-UCL41193/Downloads/9789241564540_eng.pdf
World Health Organization (WHO). Chagas disease (American trypanosomiasis). 2020. https://www.who.int/health-topics/chagas-disease#tab=tab_1
How to Cite
Copyright (c) 2021 Lucas Silva Barcelos; Amanda Aparecida Silva de Aguiar; Fernando Nunes Gavioli Boni; Luiz Euribel Prestes Carneiro; Thaís Batista de Carvalho; Eliana Peresi-Lordelo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.